France· FR:63975542
THALIDOMIDE BMS 50 mg, gélule
A thalidomide product containing thalidomide, registered in France by BRISTOL-MYERS SQUIBB PHARMA (IRLANDE). The same ATC class is registered in 15 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Thalidomide is registered in 15 of 19 countries.
Countries holding a registration under ATC L04AX02 (thalidomide), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 8 of them publish a price we can compare per daily dose
Thalidomide · ATC L04AX02
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- United Kingdom
- United Statesprice
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- THALIDOMIDE
- Manufacturer
- BRISTOL-MYERS SQUIBB PHARMA (IRLANDE)
- Country
- France (FR)
- ATC code
- L04AX02
- ATC class
- Thalidomide
- Defined daily dose
- 0.2 g, O
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009572677662 plaquette(s) thermoformée(s) PVC polychlortrifluoroéthylène aluminium de 14 gélule(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
902 interactions on record for thalidomide.
Graded by severity as the source publishes them — 176 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Thalidomide · interactions on record
902 records
- 176 severe
- 583 moderate
- 143 info
Most severe, free to view
- PapaverineA03AD01severe
- PrednisoloneA07EA01severe
- HydrocortisoneA07EA02severe
- PrednisoneA07EA03severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Thalidomide in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomThalidomide 50mg capsulesAccord-UK Ltd
- NetherlandsThalidomide BMS 50 mg harde capsulesBristol-Myers Squibb Pharma EEIG
- SpainTALIDOMIDA ACCORD 50 MG CAPSULAS DURAS EFGAccord Healthcare S.L.U.
- PolandThalidomide AccordAccord Healthcare Polska Sp. z o.o.
- SwedenThalidomide BMS 50 mg Kapsel, hårdBristol-Myers Squibb Pharma EEIG
- IrelandThalidomide BMS 50 mg hard capsulesBristol-Myers Squibb Pharmaceuticals uc
- IcelandThalidomide BMSBristol-Myers Squibb Pharma EEIG*
- NorwayThalidomide BMSBristol-Myers Squibb Pharma EEIG
Authorised across Europe · EMA
The same active substance is authorised in 16 EEA countries. Names it is sold under:
- Cyprus · Thalidomide Accord
- Germany · Thalidomid Zentiva
- Denmark · Thalidomid Accord, Thalidomide Zentiva
- Spain · Taliodmida Accord
- United Kingdom (Northern Ireland) · Thalidomide Accord-Uk, Thalidomide Eugia (Uk)
- Hungary · Thalidomide Accord
- Iceland · Thalidomide Bms
- Italy · Talidomide Accord, Talidomide Aurobindo
- Liechtenstein · Thalidomide Bms
- Malta · Thalidomide Accord
- Netherlands · Thalidomide, Thalidomide Milstein
- Norway · Thalidomide Bms, Thalidomide Zentiva
- Portugal · Talidomida Accord, Talidomida Generis
- Romania · Talidomidă Accord
- Sweden · Thalidomide Zentiva
- Slovenia · Talidomid Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d58ebb35-ac96-4757-8555-8dbea102602f GET /v1/drugs/d58ebb35-ac96-4757-8555-8dbea102602f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63975542",
"date_amm": "2008-04-16",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/08/443",
"substance": "THALIDOMIDE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about thalidomide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.